Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
3,05 USD | -7,58 % | +39,27 % | -2,24 % |
Resumen de negocios
Número de empleados: 11
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Founder | 79 | 01/09/15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 19/07/23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 08/11/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 01/06/16 |
Founder | 79 | 01/09/15 | |
Director/Board Member | 61 | 05/07/23 | |
Samir R. Patel
CEO | Chief Executive Officer | 55 | 29/11 |
Director/Board Member | 68 | 23/01/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 13 234 315 298 | 13 101 972 145 ( 99,00 %) | 0 | 99,00 % |
Información de la empresa
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+929 274 7510
http://www.akaritx.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,24 % | 36,65 M | |
+17,73 % | 124 mil M | |
+16,88 % | 111 mil M | |
-9,04 % | 23,17 mil M | |
+4,37 % | 22,94 mil M | |
-38,15 % | 17,42 mil M | |
-7,75 % | 17,42 mil M | |
-15,59 % | 16,9 mil M | |
+3,42 % | 13,71 mil M | |
+29,63 % | 11,82 mil M |
- Bolsa de valores
- Acciones
- Acción AKTX
- Empresa Akari Therapeutics, Plc